Dashenlin Pharmaceutical Group Co., Ltd. Class ASSE: 603233

Indicative Announcement on Suspending Conversion of “Dashenlin Convertible Bonds" during the Implementation of Dividend Distribution for 2025

· Issued by Dashenlin Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Indicative Announcement on Suspending Conversion of “Dashenlin Convertible Bonds" during the Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment